Table 1.
Case | Age (years), sex | Previous lumbar surgery | Antecedent surgical levels | Procedure | Time to fracture (days) | Sacral fracture treatment | Bone mineral density | Past medical history | Reference article |
---|---|---|---|---|---|---|---|---|---|
1 | 60, male | None | L5-S1 | Staged ALIF (PEEK cage with anterior plating)/PSF | 1 | PSF L4-ilium | Osteopenia | COPD, DMII, HTN, OSA, morbid obesity | — |
2 | 76, male | None | L5-S1 | Staged ALIF (PEEK cage with integrated fixation)/PSF | 53 | PSF L4-ilium | Osteopenia | HTN, OSA | — |
3 | 66, male | None | L5-S1 | Staged ALIF (PEEK cage with integrated fixation)/PSF | 114 | PSF L4-ilium | Normal | DMII, CVA, PVD | — |
4 | 73, female | None | L5-S1 | ALIF (PEEK cage with integrated fixation) | 17 | PSF L5-S2AI | Osteopenia | HTN, HLD, DMII, hypothyroidism | — |
5 | 53, male | None | L5-S1 | ALIF (femoral ring allograft with anterior plating) | 31 | PSF L5-S2AI | Normal | Hypothyroidism | — |
6 | 31, female | None | L5-S1 | ALIF (titanium treaded cage) | 3 | L4-S1 ALIF/PSF | NA | Depression, chronic pain | — |
7 | 41, female | None | L4-S1 | PLIF | 3 months | PSF w/ sacral hooks | Normal | NA | Bose et al 23 |
8 | 39, male | None | L5-S1 | ALIF | 34 days | L5-S1 PSF | NA | NA | Lastfogel et al 29 |
9 | 36, male | None | L5-S1 | ALIF | 38 days | L5-S1 PSF | NA | NA | Lastfogel et al 29 |
10 | 48, male | None | L5-S1 | ALIF | 13 days | L5-S1 PSF | NA | NA | Lastfogel et al 29 |
11 | 72, male | None | L5-S1 | ALIF | 9 days | L5-S1 PSF | NA | NA | Phan et al 30 |
12 | 70, male | Decompression | L4-S1 | L4-S1 TLIF and PSF | 21 days | L4-ilium | Osteopenia | Pemphigus | Buell et al 31 |
13 | 66, male | None | L5-S1 | L5-S1 TLIF and PSF | 28 days | L4-ilium | Osteoporosis | COPD, smoker | Buell et al 31 |
14 | 76, female | None | L4-S1 | L4-S1 PSF | 21 days | L4-ilium | Osteoporosis | Hypothyroidism | Buell et al 31 |
15 | 69, female | None | L4-S1 | L4-S1 TLIF and PSF | 21 days | L4-ilium | Osteoporosis | Hyperparathyroidism, hypothyroidism, RA on prednisone | Buell et al 31 |
16 | 52, female | None | L4-S1 | L4-S1 PSF | Several months | L2-ilium | NA | NA | Hsieh et al 51 |
17 | 53, female | Decompression | L4-S1 | PSF/ALIF | 4 months | Brace therapy, osteoporosis tx | Osteoporosis | SLE, long-term prednisone | Elias et al 27 |
18 | 61, female | None | L5-S1 | PSF/PLIF | First few days | TLSO, osteoporosis tx | Osteopenia | Breast cancer s/p mastectomy, radiation, chemotherapy; neuromuscular scoliosis; polio | Fourney et al 28 |
19 | 57, female | None | L4-S1 | PSF | 2 months | Encouraged activity | NA | Morbid obesity, HTN, OSA | Khan et al 25 |
20 | 57, female | L5-S1 PLIF | L4-S1 | PSF | 6 weeks | Water therapy, pain control | NA | DMII, obesity | Khan et al 25 |
21 | 70, female | None | L4-S1 | PSF | 2 weeks | Conservative management | Osteoporosis | n/a | Mathews et al 24 |
22 | 57, female | None | L4-S1 | PSF/PLIF | 9 days | Short-period immobilization, orthotic | Osteoporosis | DMII, hepatitis C, COPD, long-term cortisone use | Pennekamp et al 26 |
Abbreviations: ALIF, anterior lumbar interbody fusion; PLIF, posterior lumbar interbody fusion; PSF, posterior spinal fusion; S2AI, s2 alar-iliac; HTN, hypertension; DMII, type II diabetes mellitus; OSA, obstructive sleep apnea; SLE, systemic lupus erythematous; COPD, chronic obstructive pulmonary disease.